http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201406307-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1f08d7ccfbc50b53c67564087d279bf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38 |
| filingDate | 2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d66a05af47a777ccd8af6aabb8825f1 |
| publicationDate | 2015-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TR-201406307-A2 |
| titleOfInvention | A formulation for the treatment of adrenal gland failure. |
| abstract | The invention relates to a formulation for the treatment of adrenal insufficiency. The formulation supports ACTH production, promotes CRH production, increases the concentration and number of glucocorticoid receptors, maintains cell wall permeability of zona fasciculata cells. |
| priorityDate | 2014-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612 |
Total number of triples: 13.